Reducing Cardiovascular Events: International Insulin Drug Trial

Reducing Cardiovascular Events: International Insulin Drug Trial
Accumulating safety data from the large, international ORIGIN trial have been reviewed by its independent data monitoring committee, who have concluded that there is no cause for concern. This six-year study, which is lead by McMaster University professors Dr. Hertzel Gerstein and Dr.



Related Posts by Categories